|
|
|
Insider
Information: |
Sharp Shalini |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
215,117 |
|
Indirect Shares
|
104,270 |
|
|
Direct
Value |
$4,317,035 |
|
|
Indirect Value
|
$46,244 |
|
|
Total
Shares |
319,387 |
|
|
Total
Value |
$4,363,279 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
6
|
Stock
price went up :
|
0
|
5
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
5.0
|
Percentage
Gain/Loss : |
0.0%
|
537.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Agenus Inc |
AGEN |
Director |
2013-01-30 |
81,311 |
2015-09-28 |
104,270 |
Premium* |
|
Ultragenyx Pharmaceutical Inc |
RARE |
EVP, Finance |
2020-10-14 |
97,812 |
|
0 |
Premium* |
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
35,000 |
2021-02-10 |
0 |
Premium* |
|
Mirati Therapeutics, Inc. |
MRTX |
|
2024-01-23 |
0 |
2021-03-26 |
0 |
Premium* |
|
Neurocrine Biosciences Inc |
NBIX |
Director |
2024-05-17 |
994 |
2024-05-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AGEN |
Agenus Inc |
CFO |
|
2009-07-15 |
4 |
S |
$1.76 |
$23,397 |
D/D |
(13,271) |
192,020 |
0 |
- |
|
AGEN |
Agenus Inc |
CFO |
|
2009-07-16 |
4 |
S |
$1.62 |
$52,625 |
D/D |
(32,525) |
159,495 |
0 |
- |
|
AGEN |
Agenus Inc |
CFO |
|
2010-01-20 |
4 |
S |
$0.85 |
$54,488 |
D/D |
(63,848) |
237,068 |
0 |
- |
|
AGEN |
Agenus Inc |
CFO |
|
2010-09-14 |
4 |
S |
$0.91 |
$1,824 |
D/D |
(2,000) |
244,098 |
0 |
- |
|
AGEN |
Agenus Inc |
CFO |
|
2011-12-21 |
4 |
S |
$2.24 |
$6,909 |
D/D |
(3,087) |
48,551 |
0 |
- |
|
AGEN |
Agenus Inc |
CFO |
|
2011-12-22 |
4 |
S |
$2.19 |
$3,391 |
D/D |
(1,548) |
47,003 |
0 |
- |
|
AGEN |
Agenus Inc |
CFO |
|
2011-12-23 |
4 |
S |
$2.20 |
$1,747 |
D/D |
(795) |
46,208 |
0 |
- |
|
AGEN |
Agenus Inc |
CFO |
|
2011-12-27 |
4 |
S |
$2.14 |
$6,105 |
D/D |
(2,853) |
43,355 |
0 |
- |
|
AGEN |
Agenus Inc |
CFO |
|
2011-12-28 |
4 |
S |
$2.09 |
$3,576 |
D/D |
(1,711) |
41,644 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2019-03-05 |
4/A |
S |
$65.52 |
$66,306 |
D/D |
(1,012) |
69,125 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2020-05-18 |
4 |
S |
$73.29 |
$1,612,260 |
D/D |
(21,985) |
100,944 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2020-05-19 |
4 |
S |
$73.32 |
$522,625 |
D/D |
(7,128) |
101,556 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2020-06-03 |
4 |
S |
$74.23 |
$759,670 |
D/D |
(10,234) |
101,208 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2020-06-04 |
4 |
S |
$74.01 |
$189,762 |
D/D |
(2,564) |
101,208 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2020-08-17 |
4 |
S |
$88.24 |
$1,271,073 |
D/D |
(14,378) |
98,187 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
EVP, Finance |
|
2020-10-14 |
4 |
S |
$87.99 |
$32,996 |
D/D |
(375) |
97,812 |
0 |
% |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Senior Vice President |
|
2015-05-01 |
4 |
OE |
$0.82 |
$815 |
D/D |
1,000 |
49,255 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Senior Vice President |
|
2015-12-10 |
4 |
OE |
$0.82 |
$9,780 |
D/D |
12,000 |
53,801 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Senior Vice President |
|
2016-10-19 |
4 |
OE |
$0.82 |
$9,780 |
D/D |
12,000 |
57,387 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2016-11-09 |
4 |
OE |
$0.82 |
$19,560 |
D/D |
24,000 |
69,387 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2016-12-23 |
4 |
OE |
$0.81 |
$5,265 |
D/D |
6,500 |
51,887 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2017-02-27 |
4 |
OE |
$0.82 |
$9,780 |
D/D |
12,000 |
63,887 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2018-05-30 |
4 |
OE |
$0.82 |
$5,298 |
D/D |
6,500 |
70,174 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2018-06-07 |
4 |
OE |
$0.82 |
$2,730 |
D/D |
3,350 |
60,178 |
0 |
- |
|
RARE |
Ultragenyx Pharmaceutical... |
CFO & Executive Vice President |
|
2018-09-25 |
4 |
OE |
$0.82 |
$2,730 |
D/D |
3,350 |
56,828 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|